PulvinarNeuro
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Careers
  • Newsroom
  • About Us

 XCSITE 100: Alpha Access Program - Currently Closed

Picture
​XCSITE 100 is a research grade tDCS/tACS device that enables high-quality double-blind tDCS/tACS studies. XCSITE 100 was designed to meet the growing need for a tDCS/tACS that allows flexible, double-blind trial designs. Many of our customers have not used tDCS/tACS before and are delighted how easy to understand and use XCSITE 100 is.

Our Alpha Access Program is currently closed, but please stay in touch for details on our upcoming products.

    Stay in Touch:

Submit

Why choose the XCSITE 100?

Ease of Use
  • Few clicks in the app and your are up and running. 
  • Easy to read and monitor session information is displayed in app. Keep your eyes on the participant and not on the stimulation device. 
  • The XCSITE 100 device only has a single button to start and stop the stimulation. That is it!
​Flexibility
  • User defined session codes for double-blind studies. 
  • Run multiple studies at the same time. Just choose which study you are working on when you open the app.
  • To run an open-label stimulation session, switch to the research mode, where you can enter the stimulation parameters right in the app.
Quality and Safety
  • Full documentation of each stimulation session in encrypted log file with time-course of the stimulation voltage and current. 
  • All stimulation parameters are validated against known safe ranges before stimulation.
  • Safety circuits monitor current and voltage and discontinue stimulation for abnormal levels.
Picture
Picture
Picture
Picture
Picture
CAUTION: Investigational Device. Limited by United States and EU law to investigational use. ​
FCOI Policy
© COPYRIGHT 2025. ALL RIGHTS RESERVED.
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Careers
  • Newsroom
  • About Us